Pricing Log in Create free account

Aldeyra Therapeutics, Inc. (ALDX) vs Clene Inc. (CLNN)

Aldeyra Therapeutics, Inc. and Clene Inc. are both Biotechnology companies. Aldeyra Therapeutics, Inc. and Clene Inc. are of similar size ($47.0M and $44.5M). Aldeyra Therapeutics, Inc. has the higher net margin (0.00% vs −20,059.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Aldeyra Therapeutics, Inc. leads on 6 and Clene Inc. on 6.

Valuation

Metric ALDX CLNN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 194.86 9.71
P/B 1.11 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 238.72 9.21
Earnings yield (55.71%) (112.90%) (33.15%)
Free cash flow yield (52.20%) (41.54%) (25.50%)

Profitability

Metric ALDX CLNN Biotechnology median
Gross margin 0.00% 70.05% 65.16%
Operating margin 0.00% (10,431.98%) 0.00%
Net margin 0.00% (20,059.90%) 0.00%
Free cash flow margin 0.00% (8,095.43%) 0.00%
Return on equity (49.48%) 237.15% (56.36%)
Return on assets (34.80%) (174.99%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALDX CLNN Biotechnology median
Revenue growth (TTM) — (31.12%) 6.02%
EPS growth (last fiscal year) 40.43% 53.26% 30.26%
Revenue growth, 5-year CAGR — (0.59%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALDX CLNN Biotechnology median
Debt to equity 0.00 (0.74) 0.00
Current ratio 4.91 3.07 4.72
Net debt to EBITDA 1.52 (0.39) 0.96

Dividend

Metric ALDX CLNN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALDX CLNN Biotechnology median
Market cap 44.48m 46.98m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack